{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:06:41Z","timestamp":1791389201424,"version":"4.3.3"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jns.2019.07.031","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T10:47:20Z","timestamp":1564224440000},"page":"116413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study"],"prefix":"10.1016","volume":"405","author":[{"given":"Khashayar","family":"Dashtipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1045-2743","authenticated-orcid":false,"given":"Charles H.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell F.","family":"Brin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.07.031_bb0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.parkreldis.2007.02.005","article-title":"Prevalence of cervical dystonia and spasmodic torticollis in the United States general population","volume":"13","author":"Jankovic","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2019.07.031_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.870060206","article-title":"Idiopathic cervical dystonia: clinical characteristics","volume":"6","author":"Chan","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.07.031_bb0015","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1212\/WNL.41.7.1088","article-title":"Cervical dystonia: clinical findings and associated movement disorders","volume":"41","author":"Jankovic","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.07.031_bb0020","series-title":"Handbook of Dystonia","first-page":"144","article-title":"Cervical dystonia","author":"Dashtipour","year":"2012"},{"key":"10.1016\/j.jns.2019.07.031_bb0025","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mds.10127","article-title":"Impact of cervical dystonia on quality of life","volume":"17","author":"Camfield","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.07.031_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-0035-1571213","article-title":"Botulinum toxin: preparations for clinical use, immunogenicity, side effects, and safety profile","volume":"36","author":"Dashtipour","year":"2016","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jns.2019.07.031_bb0035","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.07.031_bb0040","series-title":"BOTOX\u00ae for Injection, for Intramuscular, Intradetrusor, or Intradermal Use, OnabotulinumtoxinA","year":"2018"},{"key":"10.1016\/j.jns.2019.07.031_bb0045","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","article-title":"Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia","volume":"65","author":"Comella","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.07.031_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/PL00007848","article-title":"A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia","volume":"249","author":"Naumann","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.07.031_bb0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.21724","article-title":"Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: randomized, double-blind, noninferiority trial","volume":"23","author":"Pappert","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.07.031_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/WNF.0b013e3181c46f48","article-title":"A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia","volume":"33","author":"Quagliato","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2019.07.031_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13311-013-0221-6","article-title":"Designing clinical trials for dystonia","volume":"11","author":"Galpern","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jns.2019.07.031_bb0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jns.2019.07.031_bb0075","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/mds.23638","article-title":"Determination of minimal clinically important change in early and advanced Parkinson\u2019s disease","volume":"26","author":"Hauser","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.07.031_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0004-9514(08)70001-1","article-title":"What does 'clinically important' really mean?","volume":"54","author":"Ferreira","year":"2008","journal-title":"Aust. J. Physiother."},{"key":"10.1016\/j.jns.2019.07.031_bb0085","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.clinthera.2015.10.014","article-title":"Effects of dalfampridine extended-release tablets on 6-minute walk distance in patients with multiple sclerosis: a post hoc analysis of a double-blind, placebo-controlled trial","volume":"37","author":"Applebee","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jns.2019.07.031_bb0090","first-page":"67","article-title":"Likelihood of reaching minimal clinically important difference in adult spinal deformity: a comparison of operative and nonoperative treatment","volume":"14","author":"Liu","year":"2014","journal-title":"Ochsner J."},{"key":"10.1016\/j.jns.2019.07.031_bb0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13075-015-0849-1","article-title":"Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity","volume":"17","author":"Pope","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jns.2019.07.031_bb0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2011.05.041","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN(R), botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia","volume":"308","author":"Comella","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.07.031_bb0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","article-title":"Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study","volume":"20","author":"Truong","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.07.031_bb0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2014.12.030","article-title":"Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE)","volume":"349","author":"Jankovic","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.07.031_bb0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2377-11-140","article-title":"Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)","volume":"11","author":"Jankovic","year":"2011","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2019.07.031_bb0120","series-title":"Therapy with Botulinum Toxin","first-page":"211","article-title":"Clinical assessments of patients with cervical dystonia","author":"Consky","year":"1994"},{"key":"10.1016\/j.jns.2019.07.031_bb0125","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/mds.25579","article-title":"Dystonia rating scales: critique and recommendations","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.07.031_bb0130","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/mds.870120414","article-title":"Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale","volume":"12","author":"Comella","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.07.031_bb0135","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.282.12.1157","article-title":"Capturing the patient's view of change as a clinical outcome measure","volume":"282","author":"Fischer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2019.07.031_bb0140","series-title":"Manual for the ECDEU Assessment Battery","author":"Guy","year":"1976"},{"key":"10.1016\/j.jns.2019.07.031_bb0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jns.2019.07.031_bb0150","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2000"},{"key":"10.1016\/j.jns.2019.07.031_bb0155","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/jama.2014.13128","article-title":"Minimal clinically important difference: defining what really matters to patients","volume":"312","author":"McGlothlin","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2019.07.031_bb0160","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1179\/jmt.2008.16.4.82E","article-title":"Clinimetrics corner: the minimal clinically important change score (MCID): a necessary pretense","volume":"16","author":"Cook","year":"2008","journal-title":"J. Man Manip. Ther."},{"key":"10.1016\/j.jns.2019.07.031_bb0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.parkreldis.2018.03.002","article-title":"Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale","volume":"52","author":"Espay","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2019.07.031_bb0170","first-page":"227","article-title":"Botulinum toxin type A products are not interchangeable: a review of the evidence","volume":"8","author":"Brin","year":"2014","journal-title":"Biologics"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1930334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1930334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:48:08Z","timestamp":1758383288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1930334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":34,"alternative-id":["S0022510X1930334X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.07.031","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116413"}}